Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technologies, Bio-Rad Reach Licensing Agreement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Idaho Technologies and Bio-Rad Laboratories announced after the close of the market on Tuesday a licensing agreement covering SYBR Green in PCR reactions and high-resolution melting.

Financial and other terms of the deal were not disclosed.

SYBR Green is a product of Life Technologies' Invitrogen business, but Idaho Technologies holds the patent for its use in PCR research, an Idaho Technology official said. During the summer, the company licensed reagents and methods covering the SYBR technology to E.I du Pont de Nemours, commonly known as DuPont.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.